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Abstract.
BACKGROUND: Up to 43% of HIV-infected patients co-infected with Mycobacterium tuberculosis experience exacerbations
of tuberculosis (TB) after commencing antiretroviral therapy (ART). These are termed immune restoration disease (IRD). It is
unclear why individual susceptibility varies.
OBJECTIVE: We investigate if single nucleotide polymorphisms (SNP) in genes encoding cytokines, chemokines and their
receptors associate with development of an IRD event in patients of two different ethnicities.
METHODS: DNA samples were available from small well-characterised groups of HIV patients treated in Cambodia (TB-IRD,
n = 17; HIV+TB+ controls, n = 55) and India (TB-IRD, n = 19; HIV+TB+ controls, n = 43). HIV patients with a TB
diagnosis but no evidence of IRD were included to control for susceptibility to TB per se. Sixteen SNP implicated in inflammation
or mycobacterial disease were genotyped.
RESULTS: Susceptibility to TB-IRD associated with carriage of TNFA-1031*T (rs1799964; P = 0.05) and SLC11A1
D543N*G (rs17235409; P = 0.04) in Cambodian patients and carriage of IL18-607*G (rs1946518; P = 0.02) and VDR FokI
(F/f)*T (rs10735810; P = 0.05) in Indian patients.
CONCLUSIONS: Associations between polymorphisms in immune-related genes and TB-IRD were found, but none were
common across two ethnicities.
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1. Introduction
Tuberculosis is the most common opportunistic in-
fection associated with HIV and is the leading cause
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of morbidity and mortality in people living with
HIV/AIDS in resource-limited settings. Combination
antiretroviral therapy (ART) has reduced the incidence
and severity of Mycobacterium tuberculosis (TB) in-
fections in HIV patients. When they begin ART, a
proportion of HIV-TB co-infected patients experi-
ence atypical presentations of tuberculosis termed im-
mune restoration disease (TB-IRD). This can occur de-
spite favourable virological responses and increases in
CD4+ T-cell counts on ART [8,10]. TB-IRD is com-
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mon in developing countries where TB is endemic such
as Cambodia and India [2,4]. We have sought com-
mon disease-associated polymorphisms by investigat-
ing genetic associations in patients of different ethnic-
ities from the developing world. Samples were avail-
able from HIV patients from Cambodia and India who
presented with TB-IRD, as well as HIV-positive TB-
positive control patients.
Single nucleotide polymorphisms (SNP) affecting
cytokines, chemokines and their receptors may influ-
ence development of an IRD event via effects on HIV
disease, on TB itself or on the response to ART [10].
We evaluated single nucleotide polymorphisms (SNP)
in inflammatory and other immune-related genes se-
lected based on a literature search for laboratory evi-
dence of functional consequences for an allele and as-
sociations with autoimmune disorders, infectious dis-
eases, respiratory and mycobacterial diseases [1]. Here
we present the associations of immune-related geno-
types on the risk of developing IRD in TB patients. A
significant association places this SNP or one in link-
age disequilibrium in the path to disease. If the associa-
tion is similar in two ethnicities, one can argue that the
SNP is biologically important and where differences
are observed between ethnicities, one can argue that
the effect is random or that the haplotypic associations
around the SNP vary with ethnicity.
2. Methods and materials
DNA samples were available from two prospec-
tive cohort studies of HIV patients beginning ART
with known TB status. Patients were monitored for 6–
12 months to establish the occurrence of IRD using
guidelines by the treating clinicians as proposed by the
International Network for the Study of HIV-associated
IRIS [8]. Both studies were approved by Human Re-
search Ethics Committees of the relevant institutions
and all participants provided written informed con-
sent.
1. HIV+ TB+ patients were recruited from the
National Centre for HIV/AIDS, Dermatology,
and Sexually Transmitted Disease, Social Health
Clinic, in Phnom Penh, Cambodia [4]. These
included 10 patients with paradoxical TB-IRD
(ie: whilst on TB treatment) and 7 with ART-
associated TB-IRD (ie: a new diagnosis of TB on
ART) [total TB-IRD patients (n = 17) and HIV+
TB+ controls (n = 55)].
2. TB-IRD patients (n = 19; all paradoxical TB-
IRD) and HIV+TB+ controls (n = 43) were re-
cruited at the Lala Ram Sarup (LRS) TB and Res-
piratory Diseases (Delhi, India) after initiating
TB therapy [2,13].
DNA samples were extracted from PBMC or saliva
using a QIAamp DNA Blood Mini Kit (QIAGEN,
Valencia, CA, USA) and stored at −80◦C. Sixteen
SNPs were genotyped using TaqMan FAM or VIC-
labelled probes and Universal PCR Master Mix (Ap-
plied Biosystems, Foster City, CA, USA). BAT1 intron
10 (rs9281523) was genotyped using a custom TaqMan
assay [17]. DNA samples were diluted to 10 ng/µL and
amplified on an ABI Prism 7900 HT (Applied Biosys-
tems) or Roche LC480 (Roche Applied Science, Indi-
anapolis, IL, USA) in 384-well microtiter plates. Ther-
mocycling involved one step of 10 min at 95◦C, fol-
lowed by 40 cycles of denaturation at 92◦C for 15 s
with annealing and extension at 60◦C for 1 min. Flu-
orescence was read on an ABI 7900 Sequence Detec-
tor (Applied Biosystems) or Roche LC480 (Roche Ap-
plied Science) using proprietary allelic discrimination
software. Repeats and non-template controls were in-
cluded in each run. The median (range) genotyping
success rate was 99% (98–100%) for each SNP in both
cohorts. Alleles are recorded as “gene-nucleotide posi-
tion*allele 1/allele 2”, with allele 1 being the most fre-
quent allele in Caucasians (previously defined as wild-
type). In accordance with our earlier publications [15,
16], TNF polymorphisms are described by their “tradi-
tional” names, TNF-308 and TNF-1031. We note that
they lie 307 and 1030 bases (resp.) from the transcrip-
tion start site [14].
Allele and genotype frequencies in each ethnic
group conformed with Hardy-Weinberg equilibrium
(HWE) when assessed using GENEPOP v3.3 [11].
Fisher’s exact test was used to identify factors associ-
ated with risk of developing TB-IRD. Results are pre-
sented as Odds ratios (OR), their 95% confidence in-
tervals (95% CI) and P values, using the homozygous
wild-type allele as the reference group. P  0.05 was
accepted as indicating a significant difference. Anal-
yses were performed using GraphPad (Prism version
5.02 for Windows, GraphPad Software, San Diego,
CA, USA). Logistic regression analyses utilised Stata
(StataCorp. 2009, Stata Statistical Software: Release
11. College Station, Texas, USA).
3. Results
A logistic regression that included all SNP, both co-
horts and CD4T-cell counts (square root transformed
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Table 1
TB-IRD associate with alleles of TNFA-1031 and SLC11A1 D543N in Cambodian patients and VDR FokI (F/f) and IL18-607 in Indian patients
Cambodia India
WT/var SNP rs no. HIV+TB+ TB-IRD 95% CI OR P HIV+TB+ TB-IRD 95% CI OR P
(n = 55) (n = 17) (n = 43) (n = 19)
Male/Female 38/17 11/6 33/10 16/3
Age (years)a 33 (25–63) 36 (26–45) 35 (18–65) 36 (18–51)
Baseline CD4+ T cells/µLa 62 (2–239) 45 (1–227) 100 (2–198) 78 (14–189)
Time between ART and IRD (days)a N/A 10 (7–89)e N/A 17 (5–109)e
10 (1–28)f
TNFA-308 G/A 1800629 22c 25c 0.3–4.3 1.2 1d 12c 16c 0.3–6.7 1.4 0.69d
TNFA-1031 C/T 1799964 47 77 1.0–12 3.6 0.05 63 47 0.2–1.6 0.53 0.28
BAT1 (intron 10) Ins C 9281523 22 31 0.5–5.5 1.6 0.51 7 10 0.2–10 1.5 0.64
IL1A + 4845 C/A 17561 9 33 0.9–25 4.8 0.08 60 63 0.4–3.6 1.2 1
IL2-330 T/G 2069762 62 37 0.1–1.2 0.37 0.09 72 79 0.4–5.3 1.5 0.76
IL4-589 C/T 2243250 50 59 0.5–4.3 1.4 0.58 30 26 0.3–2.8 0.82 1
IL10-1082 A/G 1800896 13 12 0.2–4.7 0.88 1 44 42 0.3–2.7 0.92 1
IL12B 3’UTR A/C 3212227 75 65 0.2–2 0.63 0.54 67 61 0.3–2.5 0.79 0.77
IL18-137 G/C 187238 30 35 0.4–4 1.3 0.77 31 42 0.5–5 1.6 0.4
IL18-607 T/G 1946518 59 76 0.6–7.8 2.2 0.26 31 63 1.2–12 3.8 0.02
CCL2-2518 A/G 1024611 73 71 0.2–3.3 0.9 1 49 58 0.5–4.3 1.4 0.59
VDR FokI (F/f) C/T 10735810 67 76 0.5–5.7 1.6 0.55 40 68 1.1–10 3.3 0.05
SLC11A1 D543N G/A 17235409 39 12 0.04–1.0 0.21 0.04 9 5 0.06–5.2 0.54 1
CD14 C(-159)T C/T 2569190 66 71 0.4–4.7 1.3 1 72 63 0.2–2.1 0.65 0.55
IL28B – SNP1 T/G 8099917 24 12 0.08–2.1 0.42 0.5 30 16 0.1–1.7 0.43 0.35
IL28B – SNP2 C/T 12979860 26 6 0.02–1.5 0.18 0.09 37 47 0.5–4.4 1.5 0.58
95% CI = 95% Confidence interval; OR = odds ratio; SNP = single nucleotide polymorphism. Significant P values < 0.05 indicated in bold.
aNonparametric data: shown as median (interquartile range); bP value calculated by Mann-Whitney test; cPercentage frequency of carriage of
minor allele; dP value calculated by Fisher’s exact test; eParadoxical TB-IRD; fART-associated TB-IRD.
to approximate a normal distribution) generated signif-
icant associations with heterozygosity at IL1A + 4845
(p = 0.05) and IL18-607 (p = 0.014). Sequential re-
moval of SNP that were not associated with TB-IRD
yielded a significant fit (p = 0.0175) with a model
including heterozygosity at SLC11 A1 D543 N (p =
0.036) and IL18-607 (p = 0.026). However these anal-
yses do not reveal ethnic differences, so we present
simple bivariate associations (Table 1).
In Cambodian patients, carriage of allele T in
TNFA-1031 (rs1799964) and allele G in SLC11A1
D543 N (rs17235409) [P = 0.05, OR = 3.6;P = 0.04,
OR = 0.21; resp] was associated with susceptibility to
TB-IRD. Trends were observed with carriage of allele
A in IL1A + 4845 and allele T in IL2-330 (P = 0.08
and P = 0.09 resp). In Indian TB patients, carriage of
allele G in IL18–607 and allele T in VDR FokI (F/f)
was associated with increased incidence of susceptibil-
ity to TB-IRD (P = 0.02, OR = 3.8; P = 0.05, OR =
3.3, resp).
4. Discussion
The results show distinct patterns of association in
the two populations. For example; carriage of the vari-
ant allele in SLC11A1 D543N conferred protection
from an IRD event in Cambodians but there was no ef-
fect in Indian patients. This SNP has been associated
with susceptibility to inflammatory diseases such as
Crohn’s disease in Greek patients [5] and Buruli ulcers
in Ghanaian patients [12]. Carriage of the variant allele
in IL18-607 conferred an almost 4-fold increased risk
of developing an IRD event in Indian patients, but had
no effect in Cambodians. No such association was ob-
served in a cohort of HIV-negative Indian pulmonary
TB patients [7], but in a Han Chinese pulmonary TB
cohort without HIV, carriage of the variant allele in
IL18-607 was associated with a decreased risk of de-
veloping TB [6].
Ethnic differences may arise when the SNP assayed
is not directly responsible for the effect, but lies in
a haplotype that is differentially carried in donors of
each ethnicity. This cannot be determined for IL18
and SLC11A1 at this time, but there is more infor-
mation about TNF. Carriage of the variant allele in
TNFA-1031 (rs1799964) in TB-IRD patients associ-
ated with a 4-fold greater risk in Cambodians, but this
was not evident in the Indian cohort. TNFA-1031*2 af-
fects neuropathy in Malay and Chinese HIV-infected
patients [3] and haplotype blocks carrying TNF-1031
differ in frequency between Indian, Chinese and Cau-
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casian donors [16]. TNFA-308*2 and TNFA-1031*2
lie in distinct “TNF block haplotypes”. A common
disease associated haplotype incorporating TNFA-308
(rs1800629) is marked by a SNP in the BAT1 gene
and is associated with venous leg ulcers and sepsis in
Caucasians [17,18]. TNF-308*2 was not found in a
small cohort of Australian HIV patients with IRD as-
sociated with non-tuberculous mycobacteria, but was
present in 24–34% of controls (p = 0.015− 0.035) [9].
The haplotype incorporating allele 2 at TNFA-308 and
BAT1(int10) is present in Asians [16], so there is a
clear dissociation between the role of TNF haplotypes
in IRD associated with TB in the developing world
(Table 1) and non-tuberculous mycobacteria in Aus-
tralia [9].
Overall there were associations between polymor-
phisms in immune-related genes and TB-IRD, but
none held in both ethnicities. Although the cohorts
were small, it can be argued that effects strong enough
to have a use in clinical practise should have emerged.
Subsequent studies should investigate patterns of link-
age disequilibrium to determine whether the associ-
ations observed here reflect ethnic differences in the
haplotypic structures across critical genes.
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